End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
29.97 CNY | -1.90% | +4.06% | -8.24% |
Apr. 23 | Salubris Pharmaceuticals' Q1 Profit Falls 5% Despite 23% Rise in Operating Income | MT |
Apr. 23 | Salubris Pharmaceuticals to Raise Capital of US Unit by $35 Million | MT |
Evolution of the average Target Price on Shenzhen Salubris Pharmaceuticals Co., Ltd.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
EPS Revisions
- Stock Market
- Equities
- 002294 Stock
- Consensus Shenzhen Salubris Pharmaceuticals Co., Ltd.